title: First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization.
authors.affiliation: Department of Nephrology, Odense University Hospital, Denmark.
authors.forename: S A
authors.initials: SA
authors.lastname: Birkeland
authors.forename: J F
authors.initials: JF
authors.lastname: Bach
authors.forename: L
authors.initials: L
authors.lastname: Chatenoud
authors.forename: K A
authors.initials: KA
authors.lastname: Jørgensen
authors.forename: M
authors.initials: M
authors.lastname: Strate
authors.forename: A
authors.initials: A
authors.lastname: Elbirk
authors.forename: N
authors.initials: N
authors.lastname: Rohr
authors.forename: V
authors.initials: V
authors.lastname: Svendsen
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006084:Graft Rejection; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D007156:Immunologic Memory; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D016853:Muromonab-CD3